Cargando…

Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation

BACKGROUND: Greater satisfaction with medication is associated with better adherence; however, specific to opioid-induced constipation (OIC), data on the relationship between medication satisfaction and efficacy are lacking. OBJECTIVE: To understand satisfaction with therapy among patients with chro...

Descripción completa

Detalles Bibliográficos
Autores principales: LoCasale, Robert J., Datto, Catherine, Margolis, Mary Kay, Coyne, Karin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397723/
https://www.ncbi.nlm.nih.gov/pubmed/27003554
http://dx.doi.org/10.18553/jmcp.2016.22.3.246
_version_ 1785083958350839808
author LoCasale, Robert J.
Datto, Catherine
Margolis, Mary Kay
Coyne, Karin S.
author_facet LoCasale, Robert J.
Datto, Catherine
Margolis, Mary Kay
Coyne, Karin S.
author_sort LoCasale, Robert J.
collection PubMed
description BACKGROUND: Greater satisfaction with medication is associated with better adherence; however, specific to opioid-induced constipation (OIC), data on the relationship between medication satisfaction and efficacy are lacking. OBJECTIVE: To understand satisfaction with therapy among patients with chronic noncancer pain and OIC. METHODS: A prospective longitudinal study was conducted in the United States, Canada, Germany, and the United Kingdom using web-based patient surveys. Patients on daily opioid therapy for ≥ 74 weeks for the treatment of chronic noncancer pain with OIC were recruited from physician offices and completed a web-based survey at baseline and weeks 2, 4, 6, 8, 12, 16, 20, and 24. When completing each survey, patients selected the remedies used in the previous 2 weeks to relieve constipation; options included natural/behavioral therapies, over-the-counter (OTC) therapies, and prescription laxatives. Patients selected the amount of relief and satisfaction with each selected therapy. Descriptive statistics were calculated; Spearman’s correlations were calculated for symptom relief and satisfaction. RESULTS: Mean age of the 489 patients who met the criteria for OIC and completed the baseline survey was 52.6 ± 11.6 years; 62% were female; 85% were white. Increasing levels of relief from constipation were associated with increasing levels of satisfaction for all agents; correlations were > 0.55 and statistically significant (P < 0.001). Among the patients who had used OTC therapies in the 2 weeks prior to baseline, 54% to 73% reported that they were somewhat or very satisfied with the therapy. Yet, of these satisfied patients, 28% to 63% experienced no or only slight relief from the therapy. Twenty percent to 79% of the patients who had used prescription laxatives in the 2 weeks prior to baseline reported being at least somewhat satisfied with the therapy. CONCLUSIONS: These results indicate that there is a high rate of inadequate response to laxatives for patients with OIC that persisted for the 6 months of this study. While increased relief from constipation was associated with increased satisfaction for all therapies, there remains a substantial number of patients who report satisfaction despite having only inadequate relief from OIC that merits further investigation.
format Online
Article
Text
id pubmed-10397723
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103977232023-08-04 Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation LoCasale, Robert J. Datto, Catherine Margolis, Mary Kay Coyne, Karin S. J Manag Care Spec Pharm Research BACKGROUND: Greater satisfaction with medication is associated with better adherence; however, specific to opioid-induced constipation (OIC), data on the relationship between medication satisfaction and efficacy are lacking. OBJECTIVE: To understand satisfaction with therapy among patients with chronic noncancer pain and OIC. METHODS: A prospective longitudinal study was conducted in the United States, Canada, Germany, and the United Kingdom using web-based patient surveys. Patients on daily opioid therapy for ≥ 74 weeks for the treatment of chronic noncancer pain with OIC were recruited from physician offices and completed a web-based survey at baseline and weeks 2, 4, 6, 8, 12, 16, 20, and 24. When completing each survey, patients selected the remedies used in the previous 2 weeks to relieve constipation; options included natural/behavioral therapies, over-the-counter (OTC) therapies, and prescription laxatives. Patients selected the amount of relief and satisfaction with each selected therapy. Descriptive statistics were calculated; Spearman’s correlations were calculated for symptom relief and satisfaction. RESULTS: Mean age of the 489 patients who met the criteria for OIC and completed the baseline survey was 52.6 ± 11.6 years; 62% were female; 85% were white. Increasing levels of relief from constipation were associated with increasing levels of satisfaction for all agents; correlations were > 0.55 and statistically significant (P < 0.001). Among the patients who had used OTC therapies in the 2 weeks prior to baseline, 54% to 73% reported that they were somewhat or very satisfied with the therapy. Yet, of these satisfied patients, 28% to 63% experienced no or only slight relief from the therapy. Twenty percent to 79% of the patients who had used prescription laxatives in the 2 weeks prior to baseline reported being at least somewhat satisfied with the therapy. CONCLUSIONS: These results indicate that there is a high rate of inadequate response to laxatives for patients with OIC that persisted for the 6 months of this study. While increased relief from constipation was associated with increased satisfaction for all therapies, there remains a substantial number of patients who report satisfaction despite having only inadequate relief from OIC that merits further investigation. Academy of Managed Care Pharmacy 2016-03 /pmc/articles/PMC10397723/ /pubmed/27003554 http://dx.doi.org/10.18553/jmcp.2016.22.3.246 Text en © 2016, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research
LoCasale, Robert J.
Datto, Catherine
Margolis, Mary Kay
Coyne, Karin S.
Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation
title Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation
title_full Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation
title_fullStr Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation
title_full_unstemmed Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation
title_short Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation
title_sort satisfaction with therapy among patients with chronic noncancer pain with opioid-induced constipation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397723/
https://www.ncbi.nlm.nih.gov/pubmed/27003554
http://dx.doi.org/10.18553/jmcp.2016.22.3.246
work_keys_str_mv AT locasalerobertj satisfactionwiththerapyamongpatientswithchronicnoncancerpainwithopioidinducedconstipation
AT dattocatherine satisfactionwiththerapyamongpatientswithchronicnoncancerpainwithopioidinducedconstipation
AT margolismarykay satisfactionwiththerapyamongpatientswithchronicnoncancerpainwithopioidinducedconstipation
AT coynekarins satisfactionwiththerapyamongpatientswithchronicnoncancerpainwithopioidinducedconstipation